About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of the Canadian Association of Gastroenterology
›
Top Articles
Journal of the Canadian Association of Gastroenterology
0.5
(top 21%)
Impact Factor
0.5
(top 21%)
extended IF
78
(top 5%)
H-Index
169
authors
2K
papers
89.2K
citations
352
citing journals
1K
citing authors
Most Cited Articles of Journal of the Canadian Association of Gastroenterology
Title
Year
Citations
A217 SIMETHICONE DECREASES BLOATING AND IMPROVES BOWEL PREPARATION EFFECTIVENESS: A SYSTEMATIC REVIEW AND META-ANALYSIS
2019
78
A228 CAN SERRATED ADENOMA DETECTION RATE (SADR) BE USED TO EVALUATE THE PERFORMANCE OF CREDENTIALED SCREENING COLONOSCOPISTS IN THE NOVA SCOTIA COLON CANCER PREVENTION PROGRAM?
2019
78
A182 ENDOSCOPIC ULTRASOUND GUIDED PANCREATIC FLUID COLLECTIONS DRAINAGE USING A LUMEN-APPOSING METAL STENT WITH ELECTRO-CAUTERY ENHANCED DELIVERY SYSTEM (HOT AXIOS); INITIAL EXPERIENCE OF A TERTIARY CARE CENTER.
2019
78
A191 HCV SCREENING VIA RAPID POINT OF CARE TESTING IN PATIENTS ON OPIATE SUBSTITUTION THERAPY IN PEEL REGION, CANADA
2019
78
A193 TIMELY HEPATITIS B IMMUNIZATION OF THE AT-RISK NEONATE: A QUALITY ASSURANCE REVIEW
2019
78
A284 ROLE OF KRT15+ STEM CELLS IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
2019
78
A240 ANTIMICROBIAL LOCK SOLUTIONS FOR PREVENTION OF CENTRAL VENOUS CATHETER INFECTIONS IN PEDIATRIC PATIENTS WITH INTESTINAL FAILURE
2019
78
A200 UNUSUAL PERIANAL MASS IN A CIRRHOTIC PATIENT: A CASE REPORT
2019
78
A201 GASTRIC VARICEAL BLEED AS A FIRST PRESENTATION OF AUTOIMMUNE HEPATITIS
2019
78
A270 EOSINOPHILIC ESOPHAGITIS IS THE LEADING CAUSE OF FOOD BOLUS IMPACTION REQUIRING ENDOSCOPY IN CALGARY, CANADA
2019
78
A281 RISK FACTORS ASSOCIATED WITH PROGRESSION OF BARRETT’S ESOPHAGUS, LOW GRADE DYSPLASIA & HIGH GRADE DYSPLASIA TO ESOPHAGEAL ADENOCARCINOMA
2019
78
A19 ROLE OF LGR5 IN DCLK1 POSITIVE CELL-DERIVED COLITIS-ASSOCIATED COLON CANCER
2019
78
A26 USE OF DRUG-TOLERANT ASSAYS IN INFLAMMATORY BOWEL DISEASE; WHAT DOES IT TELL US?
2019
78
A36 HUMAN INTERLEUKIN-4 EDUCATED MACROPHAGES SUPPRESS DNBS-INDUCED COLITIS IN MICE
2019
78
A37 DEFECTS IN INTESTINAL MUCUS DISRUPTS THE REPERTOIRE OF DEVELOPING T CELLS IN THE THYMUS
2019
78
A44 ELUXADOLINE FOR THE TREATMENT OF ABDOMINAL PAIN IN ADULTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME WHO REPORT INADEQUATE RESPONSE TO LOPERAMIDE
2019
78
A55 CELL-MEDIATED DELIVERY OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) IS NEUROPROTECTIVE FOR MYENTERIC NEURONS
2019
78
A56 ACTIVATION OF COLONIC AFFERERNT NERVES BY DEOXYCHOLIC ACID
2019
78
A59 EXPLORING THE ROLE OF MICROBIOTA IN GASTROINTESTINAL MOTILITY
2019
78
A81 SBF AND RAB21: TWO AUTOPHAGY REGULATORS INVOLVED IN INTESTINAL STEM CELL DIFFERENTIATION
2019
78
A86 EXPLORING GENE-ENVIRONMENT INTERACTIONS IN CROHN’S DISEASE: THE EFFECT OF VITAMIN D DEFICIENCY ON INTESTINAL HOMEOSTASIS IN THE CONTEXT OF SUSCEPTIBILITY GENE NOD2L1007FS
2019
78
A88 IMAGING UTILIZATION TRENDS IN IBD (1999–2016)
2019
78
A89 EMERGING THERAPEUTIC TARGETS FOR INFLAMMATORY BOWEL DISEASE-COLORECTAL CANCER: CASE STUDY ANALYSIS
2019
78
A105 HIGH ADHERENCE TO SURVEILLANCE GUIDELINES IN IBD RESULTS IN LOW CRC AND DYSPLASIA RATES, WHILE RATES OF DYSPLASIA AND CANCER ARE LOW BEFORE THE SUGGESTED START OF SURVEILLANCE. RESULTS FROM A TERTIARY IBD CENTER.
2019
78
A124 IMPROVEMENT IN DISEASE ACTIVITY IS ASSOCIATED WITH LESS DISABILITY IN A PROSPECTIVE STUDY OF PEDIATRIC TRANSITION PATIENTS WITH IBD
2019
78
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.